Arcoma AB (STO:ARCOMA)
8.34
+0.32 (3.99%)
Jul 24, 2026, 10:48 AM CET
Arcoma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 33.94 | 35.32 | 13.38 | 5 | 9.66 | 4.83 |
Cash & Short-Term Investments | 33.94 | 35.32 | 13.38 | 5 | 9.66 | 4.83 |
Cash Growth | 313.98% | 164.03% | 167.47% | -48.23% | 99.92% | -43.70% |
Accounts Receivable | 18.01 | 13.23 | 15.43 | 16.72 | 24.93 | 15.81 |
Other Receivables | 1.83 | 1.87 | 2.12 | 2.54 | 1.61 | 1.25 |
Total Trade Receivables | 19.84 | 15.1 | 17.55 | 19.26 | 26.54 | 17.06 |
Inventory | 25.72 | 23.63 | 23.94 | 28.03 | 28.3 | 19.79 |
Other Current Assets | 2.51 | 2.52 | 2.52 | 2.37 | 2.43 | 1.54 |
Total Current Assets | 82 | 76.56 | 57.38 | 54.66 | 66.93 | 43.22 |
Net Property, Plant & Equipment | 1.3 | 1.13 | 1.14 | 1.39 | 1.64 | 1.89 |
Other Intangible Assets | 16.57 | 16.78 | 18.49 | 18.73 | 22.67 | 23.51 |
Goodwill | - | - | - | 0.67 | 2.01 | 3.35 |
Other Long-Term Assets | 1.97 | 2.18 | 3.45 | 6.52 | 7.09 | 7.31 |
Total Assets | 101.84 | 96.65 | 80.46 | 81.96 | 100.33 | 79.27 |
Accounts Payable | 19.56 | 15.53 | 14.21 | 21.44 | 23.14 | 12.24 |
Accrued Expenses | 5.45 | 5.52 | 6.12 | 6.29 | 4.58 | 5.21 |
Short-Term Debt | - | - | - | - | 18.28 | 9.93 |
Current Portion of Long-Term Debt | - | - | - | 1.95 | 2.94 | 4.87 |
Unearned Revenue | 0.34 | 0.01 | - | 0.64 | 0.61 | - |
Other Current Liabilities | 0.95 | 0.87 | 0.8 | 0.9 | 0.85 | 0.76 |
Total Current Liabilities | 26.3 | 21.92 | 21.13 | 31.2 | 50.39 | 33.01 |
Long-Term Debt | - | - | - | 1.93 | 3.87 | 1.81 |
Other Long-Term Liabilities | - | - | - | 0.17 | 0.19 | 0.41 |
Total Long-Term Liabilities | - | - | - | 2.1 | 4.07 | 2.22 |
Total Liabilities | 26.3 | 21.92 | 21.13 | 33.3 | 54.46 | 35.23 |
Common Stock | 28.62 | 28.62 | 26.37 | 26.37 | 26.37 | 26.1 |
Additional Paid-in Capital | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 |
Retained Earnings | 43.18 | 42.37 | 29.22 | 18.54 | 15.76 | 14.19 |
Shareholders' Equity | 75.54 | 74.73 | 59.33 | 48.66 | 45.88 | 44.04 |
Total Liabilities & Equity | 101.84 | 96.65 | 80.46 | 81.96 | 100.33 | 79.27 |
Total Debt | - | 0 | 0 | 3.87 | 25.09 | 16.61 |
Net Cash (Debt) | 33.94 | 35.32 | 13.38 | 1.13 | -15.43 | -11.78 |
Net Cash Growth | 313.98% | 164.03% | 1085.82% | - | - | - |
Net Cash Per Share | 2.41 | 2.46 | 1.01 | 0.09 | -1.18 | -0.91 |
Book Value | 75.54 | 74.73 | 59.33 | 48.66 | 45.88 | 44.04 |
Book Value Per Share | 5.37 | 5.20 | 4.50 | 3.69 | 3.51 | 3.40 |
Tangible Book Value | 58.97 | 57.95 | 40.85 | 29.26 | 21.2 | 17.18 |
Tangible Book Value Per Share | 4.19 | 4.03 | 3.10 | 2.22 | 1.62 | 1.33 |